GURUFOCUS.COM » STOCK LIST » USA » NYSE » Stryker Corp (NYSE:SYK) » Definitions » EPS without NRI
Switch to:

Stryker (NYSE:SYK) EPS without NRI

: $7.08 (TTM As of Jun. 2023)
View and export this data going back to 1988. Start your Free Trial

Stryker's earnings per share without non-recurring items for the three months ended in Jun. 2023 was $1.93. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was $7.08.

During the past 12 months, Stryker's average earnings per share (NRI) Growth Rate was 30.40% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 4.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 6.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Stryker's EPS without NRI or its related term are showing as below:

SYK' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -42.6   Med: 19.6   Max: 153
Current: 4

During the past 13 years, Stryker's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 153.00% per year. The lowest was -42.60% per year. And the median was 19.60% per year.

SYK's 3-Year EPS without NRI Growth Rate is ranked worse than
56.9% of 696 companies
in the Medical Devices & Instruments industry
Industry Median: 9.95 vs SYK: 4.00

Stryker's EPS (Diluted) for the three months ended in Jun. 2023 was $1.93. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $7.08.

Stryker's EPS (Basic) for the three months ended in Jun. 2023 was $1.95. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $7.15.


Stryker EPS without NRI Historical Data

The historical data trend for Stryker's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.34 5.48 4.20 5.21 6.17

Stryker Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 2.14 1.47 1.54 1.93

Competitive Comparison

For the Medical Devices subindustry, Stryker's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Stryker EPS without NRI Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's EPS without NRI distribution charts can be found below:

* The bar in red indicates where Stryker's EPS without NRI falls into.



Stryker EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker  (NYSE:SYK) EPS without NRI Explanation

A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Stryker EPS without NRI Related Terms

Thank you for viewing the detailed overview of Stryker's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (NYSE:SYK) Business Description

Stryker logo
Traded in Other Exchanges
Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Skeete Tatum Lisa M director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Sherilyn S Mccoy director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Rajeev Suri director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Mary K Brainerd director 8170 33RD AVENUE SOUTH, BLOOMINGTON MN 55425
Graham A Mclean officer: President, Asia-Pacific 1 CORPORATE AVENUE ROWVILLE, VICTORIA C3 3178
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Yin C Becker officer: VP, Comm. & Public Affairs 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Bijoy Sagar officer: VP, Chief Information Officer 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Michael Damon Hutchinson officer: General Counsel 2825 AIRVIEW BLVD, KALAMAZOO MI 49002